TrialAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons2018

De novo donor-specific antibodies in belatacept-treated vs cyclosporine-treated kidney-transplant recipients: Post hoc analyses of the randomized phase III BENEFIT and BENEFIT-EXT studies.

R A Bray et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.